1. Home
  2. EDSA vs SNTG Comparison

EDSA vs SNTG Comparison

Compare EDSA & SNTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EDSA
  • SNTG
  • Stock Information
  • Founded
  • EDSA 2015
  • SNTG 2009
  • Country
  • EDSA Canada
  • SNTG China
  • Employees
  • EDSA N/A
  • SNTG 14
  • Industry
  • EDSA Biotechnology: Pharmaceutical Preparations
  • SNTG Finance: Consumer Services
  • Sector
  • EDSA Health Care
  • SNTG Finance
  • Exchange
  • EDSA Nasdaq
  • SNTG Nasdaq
  • Market Cap
  • EDSA 6.2M
  • SNTG 5.2M
  • IPO Year
  • EDSA N/A
  • SNTG 2021
  • Fundamental
  • Price
  • EDSA $1.70
  • SNTG $1.85
  • Analyst Decision
  • EDSA Strong Buy
  • SNTG
  • Analyst Count
  • EDSA 1
  • SNTG 0
  • Target Price
  • EDSA $21.00
  • SNTG N/A
  • AVG Volume (30 Days)
  • EDSA 17.7K
  • SNTG 166.8K
  • Earning Date
  • EDSA 02-07-2025
  • SNTG 12-17-2024
  • Dividend Yield
  • EDSA N/A
  • SNTG N/A
  • EPS Growth
  • EDSA N/A
  • SNTG N/A
  • EPS
  • EDSA N/A
  • SNTG N/A
  • Revenue
  • EDSA N/A
  • SNTG $146,472.00
  • Revenue This Year
  • EDSA N/A
  • SNTG N/A
  • Revenue Next Year
  • EDSA N/A
  • SNTG N/A
  • P/E Ratio
  • EDSA N/A
  • SNTG N/A
  • Revenue Growth
  • EDSA N/A
  • SNTG N/A
  • 52 Week Low
  • EDSA $1.55
  • SNTG $1.65
  • 52 Week High
  • EDSA $5.99
  • SNTG $3.97
  • Technical
  • Relative Strength Index (RSI)
  • EDSA 40.80
  • SNTG 46.91
  • Support Level
  • EDSA $1.56
  • SNTG $1.65
  • Resistance Level
  • EDSA $1.97
  • SNTG $1.91
  • Average True Range (ATR)
  • EDSA 0.15
  • SNTG 0.13
  • MACD
  • EDSA 0.02
  • SNTG -0.00
  • Stochastic Oscillator
  • EDSA 31.84
  • SNTG 41.67

About EDSA Edesa Biotech Inc.

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.

About SNTG Sentage Holdings Inc.

Sentage Holdings Inc is a financial service provider that offers a comprehensive range of financial services across consumer loan repayment and collection management, loan recommendation, and prepaid payment network services in China.

Share on Social Networks: